arsenic trioxide has been researched along with 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, T; Fukuda, M; Hojo, M; Inubushi, T; Miyamoto, S; Muraki, K; Nozaki, K; Onishi, N; Saiki, M; Satow, T; Saya, H; Shiino, A; Tanigaki, K; Yamada, S; Yoshimura, Y | 1 |
| Abolghasemi, H; Anoushirvani, AA; Bashash, D; Pourbagheri-Sigaroodi, A; Safaroghli-Azar, A; Sayyadi, M | 1 |
2 other study(ies) available for arsenic trioxide and 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one
| Article | Year |
|---|---|
Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Cell Differentiation; Cell Proliferation; Disease Progression; ErbB Receptors; Female; Glioblastoma; Hedgehog Proteins; Humans; Magnetic Resonance Imaging; Male; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Oxides; Proto-Oncogene Proteins c-myc; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis.
Topics: Antineoplastic Agents; Arsenic Trioxide; Cell Line, Tumor; Genes, myc; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Proto-Oncogene Proteins c-myc; Thiazoles | 2020 |